Key result
Cardiac magnetic resonance imaging is an important modality for diagnosing non-ischemic cardiomyopathies, quantifying ventricular function, establishing etiology, and determining prognosis.
Cardiac magnetic resonance imaging is an important modality for the diagnosis, risk stratification, and prognosis of non-ischemic cardiomyopathies.
Supports CMR consideration in non-ischemic cardiomyopathies; leaves open need for prospective outcome trials.
Non-ischemic cardiomyopathies include a wide spectrum of disease states afflicting the heart, whether a primary process or secondary to a systemic condition. Cardiac magnetic resonance imaging (CMR) has established itself as an important imaging modality in the evaluation of non-ischemic cardiomyopathies. CMR is useful in the diagnosis of cardiomyopathy, quantification of ventricular function, establishing etiology, determining prognosis and risk stratification. Technical advances and extensive research over the last decade have resulted in the accumulation of a tremendous amount of data with regards to the utility of CMR in these cardiomyopathies. In this article, we review CMR findings of various non-ischemic cardiomyopathies and focus on current literature investigating the clinical impact of CMR on risk stratification, treatment, and prognosis.
No takes yet. Share an insight, caveat, or question.
Kevin Kalisz (2016) conducted a review in Non-ischemic cardiomyopathies. Cardiac magnetic resonance imaging (CMR) was evaluated. Cardiac magnetic resonance imaging is an important modality for diagnosing non-ischemic cardiomyopathies, quantifying ventricular function, establishing etiology, and determining prognosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: